Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Advances in interventional cardiology.

D R Holmes1, R E Vlietstra, S J Reiter

  • 1Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55905.

Mayo Clinic Proceedings
|April 1, 1990
PubMed
Summary

Interventional cardiology advances, including percutaneous transluminal coronary angioplasty (PTCA), atherectomy, stenting, and laser therapy, are expanding treatment options for coronary artery disease. These innovations improve patient selection and outcomes for conditions like angina and myocardial infarction.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Maturation and culture affect the metabolomic profile of oocytes and follicular cells in young and old mares.

Frontiers in cell and developmental biology·2024
Same author

Equine maternal aging affects the metabolomic profile of oocytes and follicular cells during different maturation time points.

Frontiers in cell and developmental biology·2023
Same author

Autogenous transfer of intracytoplasmic sperm injection-produced equine embryos into the uterus of the oocyte donor during the same oestrous cycle.

Reproduction, fertility, and development·2019
Same author

Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure.

Journal of the American College of Cardiology·2000
Same author

Predictors of improvement in left ventricular ejection fraction with carvedilol for congestive heart failure.

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology·2000
Same author

Cigarette smoking status and outcome among patients with acute coronary syndromes without persistent ST-segment elevation: effect of inhibition of platelet glycoprotein IIb/IIIa with eptifibatide. The PURSUIT trial investigators.

American heart journal·2000

Area of Science:

  • Interventional Cardiology
  • Cardiovascular Medicine
  • Medical Technology

Background:

  • Interventional cardiology is rapidly expanding due to technological advancements and broader patient eligibility.
  • Coronary artery disease (CAD) management increasingly relies on minimally invasive procedures.
  • Stable angina, unstable angina, and acute myocardial infarction are key indications for intervention.

Purpose of the Study:

  • To review current and emerging technologies in interventional cardiology.
  • To highlight the role of various procedures in treating coronary artery disease.
  • To discuss the impact of new technologies on patient selection and treatment efficacy.

Main Methods:

  • Review of percutaneous transluminal coronary angioplasty (PTCA) as a primary treatment.

Related Experiment Videos

  • Description of atherectomy for lesion debulking and post-PTCA management.
  • Explanation of intracoronary stent insertion for dissection, closure, and restenosis prevention.
  • Evaluation of intracoronary laser therapy as an adjunct or standalone treatment.

    • Main Results:

    • PTCA remains the cornerstone for treating a growing number of CAD patients.
    • Atherectomy effectively removes atheromatous plaque and intimal flaps.
    • Intracoronary stents significantly address dissections, acute closure, and aim to reduce restenosis.
    • Laser therapy shows promise for diffuse disease, acute occlusion, and restenosis prevention.

    Conclusions:

    • Technological progress is driving significant growth in interventional cardiology.
    • A diverse toolkit of procedures, including PTCA, atherectomy, stenting, and laser therapy, offers comprehensive management for CAD.
    • These advancements enhance treatment strategies for various manifestations of coronary artery disease, improving patient care.